4410995 Public Hearing Notices on B20-127, “Prescription Drug Monitoring Program Amendment Act of 2013” and PR20-280, “Health Services Planning Regulations Approval Resolution of 2013”
-
Council of the District of Columbia
Committee on Health
Notice of Public Hearing
1350 Pennsylvania Ave., N.W., Washington, D.C. 20004
COUNCILMEMBER YVETTE M. ALEXANDER, CHAIRPERSON
COMMITTEE ON HEALTH ANNOUNCES A PUBLIC HEARING
on
Bill 20-127, the “Prescription Drug Monitoring Program Amendment Act of 2013”
and
Proposed Resolution 20-280, the “Health Services Planning Regulations Approval Resolution of 2013”
on
Friday, July 12, 2013
11:00 a.m., Room 120, John A. Wilson Building
1350 Pennsylvania Avenue, N.W.
Washington, D.C. 20004
Councilmember Yvette M. Alexander, Chairperson of the Committee on Health, announces a public hearing on Bill 20-127, the “Prescription Drug Monitoring Program Amendment Act of 2013” and Proposed Resolution 20-280, the “Health Services Planning Regulations Approval Resolution of 2013.” The public hearing will be held at 11:00 a.m. on Friday, July 12, 2013 in Room 120 of the John A. Wilson Building.
Bill 20-127 and Proposed Resolution 20-280 have been referred to the Committee on Health. The purpose of Bill 20-127 to improve the District’s ability to identify and reduce diversion of prescription drugs in 18 an efficient and cost effective manner that will not impede the appropriate medical 19 utilization of controlled substances; and to enhance patient care by providing prescription 20 monitoring information that will assure legitimate use of controlled substances in health care, 21 including palliative care, research and other medical and pharmacological uses. The purpose of PR20-280 is to approve the proposed rules to implement the Health Services Planning Program Reestablishment Act of 1996.
Those who wish to testify should contact Ms. Rayna Smith, Committee Director, at (202) 741-2111 or via e-mail at rsmith@dccouncil.us and provide their name, address, telephone number, organizational affiliation and title (if any) by close of business on Wednesday, July 10, 2013. Persons wishing to testify are encouraged, but not required, to submit 15 copies of written testimony. If submitted by the close of business on Wednesday, July 10, 2013, the testimony will be distributed to Councilmembers before the hearing. Witnesses should limit their testimony to four minutes; less time will be allowed if there are a large number of witnesses.
If you are unable to testify at the hearing, written statements are encouraged and will be made a part of the official record. Copies of written statements should be submitted to Ms. Rayna Smith, Committee Director, Room 115 of the Wilson Building, 1350 Pennsylvania Avenue, N.W. Washington, D.C. 20004. The record will close at 5:00 p.m. on Friday, July 26, 2013.
